Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,293Revenue $M428Net Margin (%)0Z-Score0
Enterprise Value $M3,190EPS $0Operating Margin %0F-Score0
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yN
Price/Book010-y EBITDA Growth Rate %0Quick Ratio0Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %0Current Ratio0Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)0Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M0ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with VPHM

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VPHMMichael Price 2014-03-31 Sold Out -2.6%$49.85 - $49.85
($49.85)
$ 49.960%Sold Out0
VPHMJohn Paulson 2014-03-31 Sold Out -0.32%$49.85 - $49.85
($49.85)
$ 49.960%Sold Out0
VPHMMario Gabelli 2014-03-31 Sold Out -0.18%$49.85 - $49.85
($49.85)
$ 49.960%Sold Out0
VPHMPrem Watsa 2014-03-31 Sold Out -0.04%$49.85 - $49.85
($49.85)
$ 49.960%Sold Out0
VPHMMichael Price 2013-12-31 Add0.7%$37.17 - $49.86
($44.71)
$ 49.9612%Add 36.75%400,000
VPHMJohn Paulson 2013-12-31 Buy 0.32%$37.17 - $49.86
($44.71)
$ 49.9612%New holding, 1300000 sh.1,300,000
VPHMMario Gabelli 2013-12-31 Buy 0.18%$37.17 - $49.86
($44.71)
$ 49.9612%New holding, 673900 sh.673,900
VPHMPrem Watsa 2013-12-31 Buy 0.04%$37.17 - $49.86
($44.71)
$ 49.9612%New holding, 10000 sh.10,000
VPHMLee Ainslie 2013-12-31 Sold Out -0.66%$37.17 - $49.86
($44.71)
$ 49.9612%Sold Out0
VPHMGeorge Soros 2013-12-31 Sold Out -0.04%$37.17 - $49.86
($44.71)
$ 49.9612%Sold Out0
VPHMMichael Price 2013-09-30 Add1.06%$29.24 - $40.78
($32.64)
$ 49.9653%Add 244.12%292,500
VPHMLee Ainslie 2013-09-30 Buy 0.66%$29.24 - $40.78
($32.64)
$ 49.9653%New holding, 1250175 sh.1,250,175
VPHMGeorge Soros 2013-09-30 Add0.02%$29.24 - $40.78
($32.64)
$ 49.9653%Add 100%100,000
VPHMJoel Greenblatt 2013-09-30 Sold Out -0.01%$29.24 - $40.78
($32.64)
$ 49.9653%Sold Out0
VPHMMichael Price 2013-06-30 Buy 0.33%$24.03 - $28.95
($26.38)
$ 49.9689%New holding, 85000 sh.85,000
VPHMGeorge Soros 2013-06-30 Buy 0.02%$24.03 - $28.95
($26.38)
$ 49.9689%New holding, 50000 sh.50,000
VPHMJoel Greenblatt 2013-06-30 Reduce-0.22%$24.03 - $28.95
($26.38)
$ 49.9689%Reduce -96.19%6,987
VPHMJoel Greenblatt 2012-12-31 Reduce-0.27%$22.24 - $30.26
($25.58)
$ 49.9695%Reduce -36.96%227,509
VPHMJoel Greenblatt 2012-09-30 Reduce-0.45%$19.86 - $30.71
($24.81)
$ 49.96101%Reduce -41.08%360,905
VPHMJoel Greenblatt 2012-06-30 Add0.41%$19.38 - $30.69
($21.88)
$ 49.96128%Add 58.94%612,563
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VPHM is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
VPHM John Paulson 2014-03-310 0Sold Out
VPHM Michael Price 2014-03-310 0Sold Out
VPHM Prem Watsa 2014-03-310 0Sold Out
VPHM Mario Gabelli 2014-03-310 0Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


VPHM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Broom Colin MDVP & Chief Scientific Officer 2012-12-24Sell17,500$22.53121.75view
Broom Colin MDVP & Chief Scientific Officer 2012-12-24Sell17,500$22.53121.75view
BROOKE PAUL ADirector 2012-12-13Sell60,000$23.87109.3view
Broom Colin MDVP & Chief Scientific Officer 2012-12-10Sell74,999$24.07107.56view
CLAYPOOL WILLIAM D MDDirector 2012-12-03Sell10,000$24.8101.45view
Wolf John Peter IIIVP, General Counsel 2012-12-03Sell18,000$24.85101.05view
DOUGHERTY MICHAEL RDirector 2012-12-03Buy2,500$25.0799.28view
GLASER ROBERTDirector 2012-11-30Sell30,000$24.78101.61view
CLAYPOOL WILLIAM D MDDirector 2012-11-28Sell17,500$24.22106.28view
CLAYPOOL WILLIAM D MDDirector 2012-11-13Sell22,500$24.93100.4view

Press Releases about VPHM :

    Quarterly/Annual Reports about VPHM:

    News about VPHM:

    Articles On GuruFocus.com
    Mario Gabelli Comments on ViroPharma Apr 30 2014 
    Mario Gabelli’s Top 5 Fourth-Quarter Stock Buys Feb 07 2014 
    Today’s Pronouncement: Value Investing Is A Lie Apr 17 2011 
    Weekly CFO Sells Article: MERU, GPS, ALSK, VPHM, COF, TLAB Mar 20 2011 
    ViroPharma Inc. (VPHM) VP, CFO Charles A Jr Rowland sells 35,000 Shares Mar 15 2011 
    ViroPharma Inc. Reports Operating Results (10-K) Feb 24 2011 
    ViroPharma Inc. Reports Operating Results (10-K/A) Dec 03 2010 
    ViroPharma Inc. Reports Operating Results (10-Q) Oct 27 2010 
    ViroPharma (VPHM) - A Tale of Two Drugs Aug 13 2010 
    ViroPharma Inc. Reports Operating Results (10-Q) Jul 28 2010 

    More From Other Websites
    Shire jumps on Allergan bid talk Apr 29 2014
    ViroPharma announces results of tender offer for its 2.00% Convertible Senior Notes Due 2017 (49KB... Feb 25 2014
    Shire Successfully Completes Tender Offer for ViroPharma Jan 31 2014
    Juniper, Synaptics Stocks Bolt Up Despite Downturn Jan 28 2014
    ViroPharma announces tender offer for its 2.00% Convertible Senior Notes Due 2017 (57KB PDF) Jan 24 2014
    VIROPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a... Jan 24 2014
    Shire Successfully Completes Tender Offer for ViroPharma Jan 24 2014
    Shire successfully completes tender offer for ViroPharma Jan 24 2014
    Shire Successfully Completes Tender Offer for ViroPharma Jan 24 2014
    Shire completes acquisition of ViroPharma Jan 23 2014
    Susan Kilsby appointed to helm of Shire and doubles FTSE chairwomen Jan 23 2014
    Tractor Supply Set to Join the S&P 500; Align Technology to Join MidCap 400; Roadrunner... Jan 16 2014
    Shire waives OFT condition relating to the acquisition of ViroPharma Inc. Jan 15 2014
    ViroPharma acquisition - OFT condition waived by Shire Jan 15 2014
    Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. Jan 15 2014
    Stocks Rebound, Market Back In Confirmed Uptrend Jan 14 2014
    Stocks Up In Afternoon; Tesla Soars On Strong Sales Jan 14 2014
    Strong finish at Shire lifts numbers to upper end of guidance Jan 14 2014
    Shire extends tender offer for ViroPharma Jan 10 2014
    Shire Extends Tender Offer for ViroPharma Jan 10 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide